Barclays
AWH

Barclays’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Barclays’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30
Closed -$160 – 5397
2023
Q3 		$160 Buy
30
+15
+100% +$57 ﹤0.01% 4536
2023
Q2 		$50 Sell
15
-246
-94% -$1.04K ﹤0.01% 4462
2023
Q1 		$1.43K Hold
261
– – ﹤0.01% 4907
2022
Q4 		$1.3K Sell
261
-8
-3% -$44 ﹤0.01% 5108
2022
Q3 		$1K Sell
269
-28
-9% -$301 ﹤0.01% 4719
2022
Q2 		$3K Sell
297
-525
-64% -$5.33K ﹤0.01% 4863
2022
Q1 		$13K Buy
+822
New +$14.2K ﹤0.01% 4556

Other funds holding AWH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Barclays's AWH Position: Q4 2023 in Review

Barclays sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2023, closing a stake of 30 shares — an estimated $160 sold.

Barclays first reported a position in AWH in Q1 2022 and held it in 7 quarters. The position peaked at $13K in Q1 2022. 24 funds tracked by Wall St. Rank hold AWH as of Q4 2023.

  • Barclays reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 30 Aspira Women's Health Inc. Common Stock shares in Q4 2023, an estimated $160.
  • Barclays first reported a position in Aspira Women's Health Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Barclays's Aspira Women's Health Inc. Common Stock position peaked at $13K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.